Get Skye Bioscience alerts:Skye Bioscience, Inc. (NASDAQ:SKYE – Free Report) – Investment analysts at HC Wainwright issued their Q3 2025 earnings per share (EPS) estimates for shares of Skye Bioscience in a research note issued to investors on Tuesday, September 30th. HC Wainwright also issued estimates for Skye Bioscience’s Q4 2025 earnings at ($0.44) EPS, FY2025 earnings at ($1.61) EPS, FY2026 earnings at ($1.84) EPS, FY2027 earnings at ($1.80) EPS, FY2028 earnings at ($2.04) EPS and FY2029 earnings at ($2.47) EPS. According to data from MarketBeat.com, Skye Bioscience presently has an average rating of “Buy” and an average target price of $14.75. Check Out Our Latest Stock Report on SKYESkye Bioscience Stock PerformanceSkye Bioscience stock opened at $4.49 on Thursday. Recommended StoriesReceive News & Ratings for Skye Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Skye Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.